XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced that it has signed a
contract to open a new COVID-19 testing facility in the San
Francisco International Airport. This location is expected to open
in mid-April.
XpresCheck will be building a pop-up facility,
pre-security, near the baggage claim area on the Arrivals level at
Terminal 3. It will host nine separate testing rooms with an
anticipated capacity to administer over 500 tests per day. COVID-19
testing options will include the Rapid Molecular COVID-19 Test and
the Polymerase Chain Reaction (PCR) Test.
Doug Satzman, XpresSpa CEO, stated, "We are
thrilled to be leveraging our existing relationship with United
Airlines to bring a new XpresCheck testing facility to the San
Francisco International Airport. We are pleased to continue to
support United’s efforts to provide their customers with testing
options to meet their destination entry requirements with our easy
rapid molecular testing protocol and convenient on-site testing
facilities. We believe providing this additional layer of safety
will be helpful to passengers and airline employees as demand for
travel continues to accelerate throughout 2021.”
“United has always said that until there is a
widely distributed vaccine, testing is the key to opening domestic
and international travel,” said Lori Augustine, vice president of
United’s San Francisco hub. “With the addition of this new
XpresCheck location, United customers traveling through San
Francisco have access to yet another convenient testing option to
help them meet the entry requirements at their final destination or
provide them with peace of mind ahead of their flight.”
“We welcome the addition of an XpresCheck™
COVID-19 Pop-Up Testing Facility at SFO,” said Airport Director
Ivar C. Satero. “As the first airport in the U.S. to launch an
onsite rapid testing capability, we understand the importance of
giving travelers convenient on-airport testing options. We thank
both United Airlines and the XpresSpa Group for bringing this
concept to SFO.”
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a
leading global health and wellness holding company. XpresSpa
Group’s core asset, XpresSpa, is a leading airport retailer of
spa services and related health and wellness products, with 45
locations in 23 airports globally. Through its XpresTest,
Inc. subsidiary, the Company provides COVID-19 screening and
testing under the XpresCheck™ brand at eleven locations in nine
airports: Boston Logan International
Airport (2), Denver International Airport, Dulles
International Airport, Houston George Bush Intercontinental
Airport, JFK International Airport, Newark Liberty
International Airport (2), Phoenix Sky Harbor
International Airport, Reagan National Airport, and Salt Lake
City International Airport. To learn more about XpresSpa
Group, visit: www.XpresSpaGroup.com.
Twitter: @xprescheck and
Instagram: @realxprescheck
About United Airlines
United's shared purpose is "Connecting People.
Uniting the World." For more information, visit united.com, follow
@United on Twitter and Instagram or connect on Facebook. The common
stock of United's parent, United Airlines Holdings, Inc., is traded
on the Nasdaq under the symbol "UAL".
About San Francisco International
Airport
SFO wants you to Travel Well. SFO works with
local, state, and federal health officials to protect against
COVID-19. Measures include enhanced cleaning protocols, hundreds of
hand sanitizer stations, physical barriers, face coverings for
everyone, and physical distancing. To learn more visit
flysfo.com/travel-well.
SFO offers nonstop service to Asia, South
Pacific, Europe, Canada, Mexico, and across the United States. For
up-to-the-minute departure and arrival information, airport maps
and details on shopping, dining, cultural exhibitions, ground
transportation and more, visit www.flysfo.com. Follow us on
www.twitter.com/flysfo and www.facebook.com/flysfo.
Forward-Looking Statements
This press release may contain "forward-looking"
statements within the meaning of Section 27A of the Securities Act
of 1933, and Section 21E of the Securities Exchange Act of 1934.
These include statements preceded by, followed by or that otherwise
include the words "believes," "expects," "anticipates,"
"estimates," "projects," "intends," "should," "seeks," "future,"
"continue," or the negative of such terms, or other comparable
terminology. In particular, these statements include, without
limitation, statements about our expectations relating to our new
XpresCheck™ concept, being able to expand testing to other
communicable diseases as well as administer vaccinations for the
seasonal flu, our positioning to be part of the national rollout of
various COVID-19 vaccinations, the degree to which our public
testing model assists passengers meet testing requirements in
select states and countries, our ability to identify and gain
access to the latest and best COVID-19 testing methodologies and
equipment, and our overall ability to manage the regulatory
challenges associated with this business line. Forward-looking
statements relating to expectations about future results or events
are based upon information available to XpresSpa Group as of
today's date and are not guarantees of the future performance of
the company, and actual results may vary materially from the
results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Grossir@xpresspagroup.com(203) 682-8253
Media:Julie
FergusonJulie@jfprmedia.com(312) 385-0098
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2023 to Apr 2024